Antidepressants for neuropathic pain.

By T. Saarto, P. Wiffen. Cochrane Database of Systematic Reviews, 2007

768 citations recorded by the source corpus.

Subfields: Anesthesiology and Pain Medicine, Pharmacology, Physiology

View Paper: https://www.semanticscholar.org/paper/16f6444f639add7e621ab5189199281502b30ec9

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Anesthesiology and Pain Medicine

1. R. Baron
2. N. Finnerup
3. T. S. Jensen
4. S. Sindrup
5. Clifford J. Woolf

In Pharmacology

1. T. S. Jensen
2. S. Sindrup
3. N. Finnerup
4. J. Katz
5. N. Attal
6. R. Baron

In Physiology

1. N. Finnerup
2. T. S. Jensen
3. R. Baron
4. S. Sindrup
5. Henry McQuay
6. N. Attal
7. Clifford J. Woolf

Citations in the corpus

• EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision (2010, background): “Final recommendations and issues for future trials The present revised EFNS guidelines confirm TCA (25– 150 mg/day), gabapentin (1200–3600 mg/day) and pregabalin (150–600 mg/day) as first line for various NP conditions (except for trigeminal neuralgia, section 3) and lidocaine plasters (up to 3 plas”
• Anxiety disorders and comorbid medical illness. (2008, neutral): “[194] Saarto T, Wiffen PJ.”
• Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders (2014, background): “ache attacks in patients with migraine [1438], and provide moderate relief of neuropathic pain [1439].”
• Understanding the co‐occurrence of anxiety disorders and chronic pain: state‐of‐the‐art (2009, background): “Recent systematic reviews and meta-analyses indicate limited evidence for the benefits of SSRIs in patients with chronic low back pain,([125]) migraine and tension type headaches,([126]) and neuropathic pain;([127]) however, we are unaware of any studies that have specifically examined the efficacy ”
• Algorithm for neuropathic pain treatment: An evidence based proposal (2005, positive): “In evaluating the literature and developing recommendations, the Cochrane Database and other recent systematic reviews were emphasized [27,31,33,50,53,68,100,109,119,129].”
• Pharmacologic management of neuropathic pain: Evidence‐based recommendations (2007, unknown): “In evaluating the literature and developing recommendations, the Cochrane Database and other recent systematic reviews were emphasized [27,31,33,50,53,68,100,109,119,129].”
• EFNS guidelines on pharmacological treatment of neuropathic pain (2006, background): “Antidepressants have recently been reviewed in two class I meta-analyses in neuropathic pain including PPN [11,14].”
• The evidence for pharmacological treatment of neuropathic pain (2010, methodology): “been proposed based on the published meta-analyses [29,31,83,115,116].”